G. Gao
Nature reviews. Drug discovery · 2002–2021
A researcher in the Science corpus: 7 papers; trusts 0 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Whom G. Gao trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts G. Gao overall
Papers from G. Gao's perspective
Ordered by how strongly the researchers G. Gao trusts endorse each paper. Same corpus, a different order for every researcher.
- The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.
- The new frontier of genome engineering with CRISPR-Cas9
- Therapeutic Genome Editing: Prospects and Challenges (Nature Medicine)
- MUSCLE: multiple sequence alignment with high accuracy and high throughput.
- MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform.
- The Pfam protein families database
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
- SeaView version 4: A multiplatform graphical user interface for sequence alignment and phylogenetic tree building.
- PartTree: an algorithm to build an approximate tree from a large number of unaligned sequences
- The Pfam protein families database
Their papers
- Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy (2002) — 1,527 citations
- Viral vector platforms within the gene therapy landscape (2021) — 1,107 citations
- Adeno-associated virus vector as a platform for gene therapy delivery (2019) — 2,093 citations
- Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo (2016) — 823 citations
- Worldwide Epidemiology of Neutralizing Antibodies to Adeno-Associated Viruses (2009) — 789 citations
- Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues (2004) — 1,049 citations
- Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. (2003) — 1,470 citations